News and Events
We are pleased to announce that the 2018 Nanomedicine and Drug Delivery Symposium will be hosted in Portland, Oregon. The objectives of this symposium are to highlight new groundbreaking discoveries and developments in nanomedicine and drug delivery. Revolutionary advances in this area require collaboration amongst researchers working in a diverse array of fields including nanotechnology, materials science, imaging, cell biology, tissue engineering, gene editing, drug and gene delivery as well as clinical research.
The symposium will take place at the Collaborative Life Science Building (CLSB), a next-generation health and science education and research facility that combines the resources and brainpower of three Oregon universities under one roof – Oregon State University (OSU), Oregon Health & Science University (OHSU) and Portland State University (PSU).
MISSION TRIP TO NICARAGUA GETS ATTENTION
Spring break conjures up images of sunny beaches and a warm surf, but for four first-year UNMC medical students it was a mission trip to the high forests of Nicaragua.
Read more ...
UNMC RESEARCHERS AIM TO IMPROVE HERNIA MESH
UNMC faculty Mark Carlson, M.D., and Jingwei Xie, Ph.D., are working together on a solution for a better hernia mesh. And they think they may have found it. Holes in the abdomen can't always be effectively sewn together, so they require a patch or "mesh." Maybe someday regenerative medicine will (literally) fill that hole. "But we're not there yet," Dr. Carlson said. Instead, physicians now mainly use synthetic materials -- plastics, which are, "Not perfect," Dr. Carlson said. The body can have adverse reactions to foreign material.
DISTINGUISHED SCIENTIST: JOSEPH VETRO, PH.D.
This profile is part of a series to highlight the researchers who will be honored at a ceremony for UNMC's 2017 Scientist Laureate, Distinguished Scientist and New Investigator Award recipients.
DR. MAHATO CO-AUTHORS NEW PHARMACEUTICAL TEXT
Ram Mahato, Ph.D., professor and chair of pharmaceutical sciences, is co-author of a new textbook, Pharmaceutical Dosage Forms and Drug Delivery, third edition.
NANOFIBER SUTURES MAY PREVENT SURGICAL SITE INFECTIONS
Jingwei Xie, Ph.D., a biomedical engineer at UNMC, has been awarded a four-year, $1.3 million grant from the National Institutes of Health (NIH) to study the nanofiber-based local delivery of immunomodulating compounds for prevention of surgical site infections (SSIs).
DR. GENDELMAN HONORED FOR HUMANITARIAN WORK
Howard Gendelman, M.D., professor and chair of the UNMC Department of Pharmacology and Experimental Neuroscience, received the Humanitarian of the Year Award from the Jewish Federation of Omaha at a ceremony on June 5. Read a story on Dr. Gendelman from the Jewish Press.
REMEMBERING: MIKE BOSKA, PH.D.
Mike Boska, Ph.D., whose expertise in magnetic resonance imaging research benefited countless scientists at UNMC, died Saturday (May 13) in a one-man glider accident near the Blair, Neb., airport. He was 59.
UNMC SCIENTISTS ACHIEVE RESEARCH MILESTONE WITH PARKINSON'S DISEASE
In an early phase human clinical trial, researchers at UNMC tested a drug that transforms the immune system for diagnostic and therapeutic gain in Parkinson's disease (PD).
THREE UNMC STUDENTS NAMED PURDUE PHARMA SCHOLARS
UNMC Graduate Studies has announced its first cohort of Purdue Pharma Scholars, a program that provides funding for UNMC graduate students conducting neuroscience, pharmaceutical science or pain research. The annual scholarships are just one aspect of larger, ongoing partnership between UNMC and Purdue Pharma L.P.
NOVEL PHARMACEUTIC ACTION FOR HIV/AIDS DISCOVERED
A research team at UNMC has used a process they call LASER ART (long-acting slow effective release antiretroviral therapy) to discover an unexpected pathway to open cell storage areas for antiviral drugs. The discovery could revolutionize current treatments for HIV/AIDS by extending the actions of disease-combating medicines.
DR. LYUBCHENKO NAMED TO THE EDUCATION BOARD AT THE AMERICAN HEALTH COUNCIL
Yuri Lyubchenko, Ph.D., professor, pharmaceutical science, College of Pharmacy, has been named to the Education Board at the American Health Council. A UNMC Distinguished Scientist in 2008, Dr. Lyubchenko has been at UNMC since 2004. His areas of expertise include nanomedicine, biophysics and nanotechnology. He has had 254 articles published in peer-reviewed publications. The American Health Council is comprised of medical leaders and innovators and includes practitioners in allied health, dentistry, obstetrics, medicine, nursing, optometry, pharmacy, psychology and other health professions. The goal of the council is to maintain and improve the physical and mental health of Americans.
MEET DISTINGUISHED SCIENTIST LARISA POLUEKTOVA, M.D., PH.D.
This profile is part of a series to highlight the researchers who will be honored at a ceremony for UNMC's 2016 Scientist Laureate, Research Leadership, Distinguished Scientist and New Investigator Award recipients.
The Distinguished Scientist Award -- which is sponsored by the chancellor -- recognizes researchers who have been among the most productive scientists in the country during the past five years.
UNMC is part of a seven-university consortium working on a three-year, $8.6 million grant from the National Institutes of Health to map the heart's nervous system. The group's goal -- to conduct research that leads to new ways to treat cardiovascular disease by targeting nerves in the heart. Irving Zucker, Ph.D., professor and chair of the UNMC Department of Cellular and Integrative Physiology, is the principal investigator for the UNMC component.
Spring break conjures up images of sunny beaches and a warm surf, but for four first-year UNMC medical students it was a mission trip t...
UNMC faculty Mark Carlson, M.D., and Jingwei Xie, Ph.D., are working together on a solution for a better hernia mesh. And they think th...
We are pleased to announce that the 2018 Nanomedicine and Drug Delivery Symposium will be hosted in Portland, Oregon. The objectives of this sy...